DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dbv Technologies Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.953 -- 00:00:06.597 Welcome to the DBV second quarter financial results and business update conference call. 00:00:06.597 -- 00:00:09.620 All participants will be in a listen-only mode. 00:00:09.620 -- 00:00:13.703 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.703 -- 00:00:18.727 key followed by zero. After today's presentation, there will be an opportunity to 00:00:18.727 -- 00:00:24.071 ask questions. To ask a question, you may press star, then one on your telephone 00:00:24.071 -- 00:00:30.342 keypad. To withdraw your question, please press the pound key, then one. 00:00:30.342 -- 00:00:34.543 Please note this event is being recorded. I would now like to turn the conference over 00:00:34.543 -- 00:00:39.564 to Katie Matthews, Investor Relations. Please go ahead. 00:00:39.665 -- 00:00:44.707 Thank you. This afternoon, DBV Technologies issued a press release that outlines 00:00:44.707 -- 00:00:49.228 our financial results for the three and six months ended June 30th, 2024. 00:00:49.228 -- 00:00:54.310 This press release is available in the Press Releases section of the DBV 00:00:54.310 -- 00:00:59.328 Technologies website. Before we begin, Please note that today's call may include 00:00:59.328 -- 00:01:04.231 a number of forward-looking statements, including but not limited to comments regarding 00:01:04.231 -- 00:01:09.395 our clinical and regulatory development plans, the design of our anticipated 00:01:09.395 -- 00:01:14.538 clinical trials, the timing and results of interactions with regulatory agencies, 00:01:14.538 -- 00:01:19.321 our forecast of our cash runway, and the ability of any of our product candidates, if 00:01:19.321 -- 00:01:24.043 approved, to improve the lives of patients with food...